Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature

References

• Hayes AR, Davar J, Caplin ME. Carcinoid heart disease: a review. Endocrinol Metab Clin North Am. 2018;47(3):671–682.
   PubMed Web of Science ®Google Scholar
• Grozinsky-Glasberg S, Grossman AB, Gross DJ. Carcinoid heart disease: from pathophysiology to treatment 'something in the way it moves'. Neuroendocrinology. 2015;101(4):263–273.
   PubMed Web of Science ®Google Scholar
• Raja SG, Bhattacharyya S, Davar J, et al. Surgery for carcinoid heart disease: current outcomes, concerns and controversies. Future Cardiol. 2010;6(5):647–655.
   PubMedGoogle Scholar
• Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–1342.
   PubMed Web of Science ®Google Scholar
• Gustafsson BI, Hauso O, Drozdov I, et al. Carcinoid heart disease. Int J Cardiol. 2008;129(3):318–324.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Toumpanakis C, Burke M, et al. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging. 2010;3(1):103–111.
   PubMed Web of Science ®Google Scholar
• Kulke MH, Benson AB, Bergsland E, et al. National Comprehensive Cancer Network: neuroendocrine tumors, clinical practice guidelines in oncology. J Natl Compr Care Netw. 2012;10(6):724–764.
   PubMedGoogle Scholar
• Karimi A, Pourafshar N, Fudge JC. Pulmonary and tricuspid valvuloplasty in carcinoid heart disease. Catheter Cardiovasc Interv. 2018;91(7):E68–E71.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Toumpanakis C, Caplin ME, et al. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol. 2008;101(3):378–381.
   PubMed Web of Science ®Google Scholar
• Castillo JG, Naib T, Zacks JS, et al. Echocardiography in functional midgut neuroendocrine tumors: when and how often. Rev Endocr Metab Disord. 2017;18(4):411–421.
   PubMed Web of Science ®Google Scholar
• Korse CM, Taal BG, de Groot CA, et al. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. J Clin Oncol. 2009;27(26):4293–4299.
   PubMed Web of Science ®Google Scholar
• Kulke MH, Hörsch D, Caplin ME, et al. Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome. J Clin Oncol. 2017;35(1):14–23.
   PubMed Web of Science ®Google Scholar
• Davar J, Connolly HM, Caplin ME, et al. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumours. An expert statement. J Am Coll Cardiol. 2017;69(10):1288–1304.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Davar J, Dreyfus G, et al. Carcinoid heart disease. Circulation. 2007;116(24):2860–2865.
   PubMed Web of Science ®Google Scholar
• Connolly HM, Schaff HV, Mullany CJ, et al. Surgical management of right sided heart disease. Circulation. 2001;104(Suppl 1):I-36–40.
   Google Scholar
• De Rosa R, Schranz D, Zeiher AM, et al. Again, two melodies in concert: transcatheter double valve replacement in Hedinger syndrome. Ann Thorac Surg. 2017;104(1):e61–e63.
   PubMed Web of Science ®Google Scholar
• Florczak E, Pęczkowska M, Konka M, et al. A 51-year-old patient with carcinoid heart disease and severe tricuspid regurgitation. Kardiol Pol. 2017;75(2):183.
   PubMed Web of Science ®Google Scholar
• Bulur S, Hsiung MC, Nanda NC, et al. Incremental value of live/real time three-dimensional transthoracic echocardiography over the two-dimensional technique in assessing carcinoid heart disease involving the aortic valve. Echocardiography. 2016;33(11):1741–1744.
   PubMed Web of Science ®Google Scholar
• Loyalka P, Schechter M, Nascimbene A, et al. Transcatheter pulmonary valve replacement in a carcinoid heart. Tex Heart Inst J. 2016;43(4):341–344.
   PubMed Web of Science ®Google Scholar
• Jahagirdar V, Kamal A, Steeds R, et al. Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease. BMJ Case Rep. 2016;2016:pii: bcr2015213693.
   Google Scholar
• Tsugu T, Iwanaga S, Murata M, et al. Bioprosthetic tricuspid valve replacement in carcinoid heart disease from primary ovarian carcinoid tumour. J Med Ultrasonics. 2015;42(3):401–403.
   PubMed Web of Science ®Google Scholar
• Khan JN, Doshi SN, Rooney SJ, et al. Transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration in carcinoid heart disease. Eur Heart J Cardiovasc Imaging. 2016;17(1):114.
   PubMed Web of Science ®Google Scholar
• Proesmans S, Van Fraeyenhove F, Dossche K, et al. Carcinoid heart disease: a remarkable recovery. Acta Clin Belg. 2015;70(6):453–456.
   PubMed Web of Science ®Google Scholar
• Conradi L, Schaefer A, Mueller GC, et al. Carcinoid heart valve disease: transcatheter pulmonary valve-in-valve implantation in failing biological xenografts. J Heart Valve Dis. 2015;24(1):110–114.
   PubMed Web of Science ®Google Scholar
• Laule M, Pschowski R, Pape UF, et al. Staged catheter-based valve treatment of severe carcinoid heart disease. Neuroendocrinology. 2016;103(3-4):259–262.
   PubMed Web of Science ®Google Scholar
• Heidecker B, Moore P, Bergsland EK, et al. Transcatheter pulmonic valve replacement in carcinoid heart disease. Eur Heart J Cardiovasc Imaging. 2015;16(9):1046.
   PubMed Web of Science ®Google Scholar
• Schaefer A, Sill B, Schoenebeck J, et al. Failing stentless bioprostheses in patients with carcinoid heart valve disease. J Cardiothorac Surg. 2015;10(1):41.
   PubMedGoogle Scholar
• Paredes A, Valdebenito M, Gabrielli L, et al. Tricuspid and pulmonary valve involvement in carcinoid syndrome. Report of two cases. Rev Med Chile. 2014;142(5):662–666.
   PubMed Web of Science ®Google Scholar
• Anselmi A, Corbineau H, Boulmier D, et al. Early diffuse coronary artery spasm after heart valve surgery in the carcinoid syndrome. J Card Surg. 2013;28(4):402–403.
   PubMed Web of Science ®Google Scholar
• Pêgo-Fernandes PM, Laurino AM, Ferronato Dde S, et al. Double valve replacement due to dysfunction secondary to carcinoid tumour. Arq Bras Cardiol. 2013;100(3):e32–4.
   PubMed Web of Science ®Google Scholar
• Hastie MJ, Souh J, Ju A, et al. Echo rounds: undiagnosed severe pulmonic regurgitation in a carcinoid patient for tricuspid valve replacement and patent foramen ovale closure. Anesth Analg. 2013;116(2):300–302.
   PubMed Web of Science ®Google Scholar
• Carrilho-Ferreira P, Silva D, Almeida AG, et al. Carcinoid heart disease: outcome after balloon pulmonary valvuloplasty. Can J Cardiol. 2013;29(6):751.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Raja SG, Toumpanakis C, et al. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease. Eur J Cardiothorac Surg. 2011;40(1):168–172.
   PubMed Web of Science ®Google Scholar
• Komoda S, Komoda T, Pavel ME, et al. Cardiac surgery for carcinoid heart disease in 12 cases. Gen Thorac Cardiovasc Surg. 2011;59(12):780–785.
   PubMedGoogle Scholar
• Takahashi H, Okada K, Asano M, et al. Bioprosthetic pulmonary and tricuspid valve replacement in carcinoid heart disease from ovarian primary cancer. Circ J. 2009;73(8):1554–1556.
   PubMed Web of Science ®Google Scholar
• Dworakowska D, Gueorguiev M, Laji K, et al. Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid – a case report. Endokrynol Pol. 2008;59(4):342–347.
   PubMedGoogle Scholar
• Voigt PG, Braun J, Teng OY, et al. Double bioprosthetic valve replacement in right-sided carcinoid heart disease. Ann Thorac Surg. 2005;79(6):2147–2149.
   PubMed Web of Science ®Google Scholar
• Warner RR. Carcinoid case presentation and discussion: the American perspective. Endocr Relat Cancer. 2003;10:489–496.
   PubMed Web of Science ®Google Scholar
• Brunaud L, Antunes L, Sebbag H, et al. Ovarian strumal carcinoid tumour responsible for carcinoid heart disease. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):124–126.
   PubMed Web of Science ®Google Scholar
• Robiolio PA, Rigolin VH, Harrison JK, et al. Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. Am J Cardiol. 1995;75(7):485–488.
   PubMed Web of Science ®Google Scholar
• Ohri SK, Schofield JB, Hodgson H, et al. Carcinoid heart disease: early failure of an allograft valve replacement. Ann Thorac Surg. 1994;58(4):1161–1163.
   PubMed Web of Science ®Google Scholar
• Lundin L, Hansson HE, Landelius J, et al. Surgical treatment of carcinoid heart disease. J Thorac Cardiovasc Surg. 1990;100(4):552–561.
   PubMed Web of Science ®Google Scholar
• DiSesa VJ, Mills RM, Jr, Collins JJ, Jr. Surgical management of carcinoid heart disease. Chest. 1985;88(5):789–791.
   PubMed Web of Science ®Google Scholar
• Forman MB, Byrd BF, III, Oates JA, et al. Two-dimensional echocardiography in the diagnosis of carcinoid heart disease. Am Heart J. 1984;107(3):492–496.
   PubMed Web of Science ®Google Scholar
• Gutierrez FR, McKnight RC, Jaffe AS, et al. Double porcine valve replacement in carcinoid heart disease. Chest. 1982;81(1):101–103.
   PubMed Web of Science ®Google Scholar
• Schoen FJ, Hausner RJ, Howell JF, et al. Porcine heterograft valve replacement in carcinoid heart disease. J Thorac Cardiovasc Surg. 1981;81(1):100–105.
   PubMed Web of Science ®Google Scholar
• Sworn MJ, Edlin GP, McGill DA, et al. Tricuspid valve replacement in carcinoid syndrome due to ovarian primary. Br Med J. 1980;280(6207):85–86.
   PubMedGoogle Scholar
• Okada RD, Ewy GA, Copeland JG. Echocardiography and surgery in tricuspid and pulmonary valve stenosis due to carcinoid-syndrome. Cardiovasc Med. 1979;4:871–881.
   Google Scholar
• McGuire MR, Pugh DM, Dunn MI. Carcinoid heart disease. Restrictive cardiomyopathy as a late complication. J Kans Med Soc. 1978;79(12):661–662.
   PubMedGoogle Scholar